COCP

$1.07+0.94%visit website

Cocrystal Pharma, Inc.

Market Cap

$21M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.61

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

19.7

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue			225	105
Research & development	954	1,619	1,371	2,142	6,086
Total operating expenses	2,089	2,481	2,581	3,289	10,440
Operating income	(2,089)	(2,481)	(2,356)	(3,184)	(10,110)
Interest expense	(22)	(47)	(22)	(10)	(101)
Income tax			0.00	0.00
Net income	(2,049)	(2,426)	(2,299)	(3,164)	(9,938)
EPS (basic) ($)	(0.19)		(0.17)	(0.23)	(0.75)
EPS (diluted) ($)	(0.19)		(0.17)	(0.23)	(0.75)
Weighted avg. shares (basic)	10,991		13,786	13,788
Weighted avg. shares (diluted)	10,991		13,786	13,788

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

18 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 9, 2026 accepted 8:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 18, 2026 accepted 4:30 PM ET	5.02Officer / director change	Document SEC ↗
Aug 17, 2026 accepted 4:15 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 3, 2026 accepted 7:15 AM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Jul 17, 2026 accepted 8:00 AM ET	5.07Shareholder vote	Document SEC ↗
Jun 9, 2026 accepted 7:00 AM ET	5.02Officer / director change	Document SEC ↗
Jun 3, 2026 accepted 7:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 26, 2026 accepted 8:30 AM ET	7.01Reg FD disclosure	Document SEC ↗
Apr 30, 2026 accepted 4:30 PM ET	7.01Reg FD disclosure	Document SEC ↗
Apr 2, 2026 accepted 8:30 AM ET	7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

36%

W/W +32.4pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-05	2026-08-06	FROST PHILLIP MD ET AL	Director	Purchase	10.0K	$0.98	$10K	1.99M	View
2026-08-03	2026-08-05	FROST PHILLIP MD ET AL	Director	Purchase	75.0K	$0.94	$71K	1.98M	View
2026-02-24	2026-02-25	FROST PHILLIP MD ET AL	Director	Purchase	20.0K	$1.00	$20K	1.91M	View
2026-02-06	2026-02-09	FROST PHILLIP MD ET AL	Director	Purchase	50.0K	$0.95	$47K	1.89M	View

Recent News

This Beaten Down Biotech Stock Has A Secret Billionaire Backer Ncis Sydney (nGext5ndB4)

Unisba Media · 2026-10-22

Cocrystal Pharma (NasdaqCM:COCP) Stock Forecast & Analyst Predictions

Simply Wall St · 2026-10-09

Cocrystal Pharma’s new CEO hopes to crack the norovirus code

Yahoo Finance · 2026-09-15

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Yahoo Finance · 2026-09-09

Cocrystal Pharma: The Strategic Reset Investors May Be Missing

Yahoo Finance · 2026-08-31

COCP: $5 Million Private Placement with OPKO Health

Yahoo Finance · 2026-08-20

Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors

Yahoo Finance · 2026-08-17

Insider Purchase: Director at $COCP Buys 75,000 Shares

Quiver Quantitative · 2026-08-05

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Yahoo Finance · 2026-08-03

COCP Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-26

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Yahoo Finance · 2026-06-03

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

Yahoo Finance · 2026-04-02

COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?

Stocktwits · 2026-04-02

Buy Vita Coco Stock. The Coconut Water Company Has Room to Grow.

Barron's · 2025-11-13

symbol__ Stock Quote Price and Forecast

CNN · 2024-03-06

Informational purposes only, not investment advice.

COCP

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Cocrystal Pharma, Inc. (COCP)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-08-05	FROST PHILLIP MD ET AL	P	10,000	$9,816
2026-08-03	FROST PHILLIP MD ET AL	P	75,000	$70,590
2026-02-24	FROST PHILLIP MD ET AL	P	20,000	$19,952
2026-02-06	FROST PHILLIP MD ET AL	P	50,000	$47,280